Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590005 · ClinicalTrials.gov registry record
Redox Determinants of Severe Asthma (a Substudy of the Severe Asthma Research Program)
A clinical trial of Asthma, sponsored by Emory University.
- Completed
- Registry status
- 225
- Enrollment target
- 1
- Study location
NCT00590005 is a study of Asthma that has completed, run by Emory University. The registered enrollment target is 225 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00590005, a study of Asthma, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 225 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypotheses: 1) Airway pH regulation is abnormal in severe asthma; 2) In severe asthma, there is formation of cytotoxic nitrogen oxides and loss of beneficial nitrogen oxides in the airways
Conditions Studied
Study Locations (1)
Georgia
- Emory Childrens Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2003-01 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00590005
The ClinicalTrials.gov registry entry for NCT00590005 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (86% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT00590005 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT00590005 about?
NCT00590005 is a clinical study titled "Redox Determinants of Severe Asthma (a Substudy of the Severe Asthma Research Program)". Hypotheses: 1) Airway pH regulation is abnormal in severe asthma; 2) In severe asthma, there is formation of cytotoxic nitrogen oxides and loss of beneficial nitrogen oxides in the airways
What is the current status of trial NCT00590005?
This trial is currently completed. The enrollment target is 225 participants. The study started on 2003-01. Estimated completion is 2011-06.
What conditions does trial NCT00590005 study?
This clinical trial studies the following conditions: Asthma.
Who is sponsoring clinical trial NCT00590005?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00590005 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.